It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.
In this episode, a panel of experts discuss identifying appropriate risk assessment strategies to accurately determine the level of VTE risk for patients.
People with HCM may need to make lifestyle changes, such as limiting their activity, to accommodate their disease. In this episode, experts will cover behavior…
HCM is a chronic and progressive disease that puts patients at risk of serious complications and co-morbidities. Early detection, disease and symptom management may help…
Watch a discussion among experts on the epidemiology of venous thromboembolism (VTE), including identifying patients at risk and discussing methods for the accurate diagnosis of…
Complicated pericarditis can occur in 15-30% of patients after an episode of acute pericarditis. This podcast will review the initial diagnosis, clinical evaluation, and treatment…
While healthcare providers may initiate corticosteroids in patients with recurrent pericarditis, patients with autoimmune rheumatic disease and cardiac involvement should also be managed in collaboration…
In this podcast learn more about the role interleukin-1 (IL-1) plays in the pathophysiology of pericarditis. Listen Now!
Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast…
Listen to this podcast to better understand the triggers causing recurrent episodes of pericarditis. Experts discuss how to assess those triggers to direct optimal therapy.
Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities. Early…
